These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3038722)

  • 21. Different doses of recombinant alpha interferon in the treatment of chronic hepatitis B patients without antibodies against the human immunodeficiency virus.
    Porres JC; Carreño V; Mora I; Gutiez J; Moreno A; Ramon y Cajal S; Marron JA; Bartolomé J
    Hepatogastroenterology; 1988 Dec; 35(6):300-3. PubMed ID: 3215626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon therapy of chronic hepatitis B virus infection in Chinese.
    Lok AS; Lai CL; Wu PC
    J Hepatol; 1986; 3 Suppl 2():S209-15. PubMed ID: 3036936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
    Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
    Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus.
    Perrillo RP; Regenstein FG; Roodman ST
    Ann Intern Med; 1986 Sep; 105(3):382-3. PubMed ID: 3017169
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life.
    Ikeda T; Lever AM; Thomas HC
    Hepatology; 1986; 6(5):962-5. PubMed ID: 2428724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant leucocyte interferon treatment of chronic hepatitis B. An analysis of two therapeutic trials.
    Dusheiko GM; Paterson AC; Pitcher L; Kassianides C; DiBisceglie AM; Song E; Kew MC
    J Hepatol; 1986; 3 Suppl 2():S199-207. PubMed ID: 3298408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.
    Wong DK; Cheung AM; O'Rourke K; Naylor CD; Detsky AS; Heathcote J
    Ann Intern Med; 1993 Aug; 119(4):312-23. PubMed ID: 8328741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon.
    Porres JC; Carreño V; Ruíz M; Marrón JA; Bartolomé J
    J Hepatol; 1989 May; 8(3):351-7. PubMed ID: 2732449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients.
    Zylberberg H; Jiang J; Pialoux G; Driss F; Carnot F; Dubois F; Brechot C; Berthelot P; Pol S
    Gastroenterol Clin Biol; 1996; 20(11):968-71. PubMed ID: 9119186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of hepatitis B virus (HBV) markers during prolonged recombinant interferon alpha-2A treatment of chronic HBV infection.
    Mora I; Porres JC; Bartolomé J; Quiroga JA; Gutiez J; Hernández Guio C; Bas C; Carreño V
    J Hepatol; 1987 Feb; 4(1):29-36. PubMed ID: 3571931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man.
    Hess G; Gerlich W; Gerken G; Manns M; Hütteroth TH; Meyer zum Büschenfelde KH
    Hepatology; 1987; 7(4):704-8. PubMed ID: 3610048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of adenine arabinoside and alpha-interferon in patients with HBeAg-positive chronic active hepatitis.
    Lee SU; Choi KH; Ha BJ; Suh SY; Han BH; Ku JY; Park BC
    Korean J Intern Med; 1990 Jan; 5(1):1-4. PubMed ID: 2271507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatment.
    Scully LJ; Shein R; Karayiannis P; McDonald JA; Thomas HC
    J Hepatol; 1987 Aug; 5(1):51-8. PubMed ID: 3655310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
    Lai CL; Lok AS; Lin HJ; Wu PC; Yeoh EK; Yeung CY
    Lancet; 1987 Oct; 2(8564):877-80. PubMed ID: 2889081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection.
    Lok AS; Lai CL; Leung EK
    Hepatology; 1990 Dec; 12(6):1266-70. PubMed ID: 2258142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.
    Ip HM; Lelie PN; Wong VC; Kuhns MC; Reesink HW
    Lancet; 1989 Feb; 1(8635):406-10. PubMed ID: 2563788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.